DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Staxyn (Vardenafil Hydrochloride Trihydrate) - Summary



STAXYN is an oral therapy for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific PDE5.

STAXYN® is indicated for the treatment of erectile dysfunction.

See all Staxyn indications & dosage >>


Published Studies Related to Staxyn (Vardenafil)

Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications. [2010]
medications... CONCLUSIONS: Vardenafil demonstrated favorable efficacy and tolerability in this

Vardenafil allows successful intercourse initiated rapidly after dosing in Japanese patients with diabetes mellitus and erectile dysfunction. [2009]
achievable in ED patients with DM... CONCLUSIONS: In this retrospective analysis, a rapid onset of activity was also

Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. [2008]
radical prostatectomy (NSRP) surgery... CONCLUSIONS: In this study of men with ED following bilateral NSRP, vardenafil

A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency. [2008]
vardenafil on nasal patency in patients at a university hospital... CONCLUSION: Objective and subjective nasal obstruction after administration of

Vardenafil in men with stable statin therapy and dyslipidemia. [2008]
data were obtained to compare safety outcomes... CONCLUSIONS: Vardenafil was demonstrated to be safe and effective for managing ED

more studies >>

Clinical Trials Related to Staxyn (Vardenafil)

Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction [Completed]
This study investigates the safety and efficacy of a new dosage form of Vardenafil, an orodispersible tablet (ODT), and compares it to the safety and efficacy of a placebo (inactive) tablet in the treatment of erectile dysfunction. After a 4-week unmedicated phase, patients will receive Vardenafil ODT or matching placebo for 12 weeks. Safety will be determined by laboratory and other evaluations. Efficacy will be determined by the results of different questionnaires and the patient diary that will be used.

Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome [Completed]
This is a controlled, randomized, multi-center prospective study of vardenafil to determine efficacy on Erectile Dysfunction (ED), tolerability and safety in men with ED and Metabolic Syndrome. This study will explore the rate of patients who do need to switch to the highest dosage based upon the expectation that most men can stay on vardenafil 10 mg PRN (pro re nata)

Diabetes & Vardenafil [Completed]
Given the protective effect of nitric oxide (NO) on the endothelium and the results obtained so far in short-term, continuous treatment with phosphodiesterase-5 (PDE5) inhibitors on parameters of endothelial function, we hypothesise that chronic treatment with vardenafil can prevent or delay the deterioration of systemic endothelial function in patients with type 2 diabetes mellitus. The favourable effect of PDE5 inhibitors on sexual function in these patients has been convincingly demonstrated in the past. Here we hypothesise that vardenafil treatment can have beneficial effects on the vascular physiology in other body districts, possibly preventing the development of microangiopathy and atherosclerotic cardiovascular disease in these patients. The main goal of this study is therefore to monitor the endothelial dysfunction during continuous treatment with vardenafil for 6 months; object of the study will be endothelin 1 and other known parameters of endothelial damage in newly diagnosed patients with type 2 diabetes mellitus.

Assess Efficacy in Subjects With Traumatic Spinal Cord Injury [Completed]
Assess efficacy of Vardenafil in patients with traumatic spinal cord injury

Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis [Recruiting]
The investigators want to analyze the effect of Vardenafil on Erectile Dysfunstion and portal hemodynamics in patients with liver cirrhosis.

more trials >>

Page last updated: 2015-08-10

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017